These are both good points, but it is also important to note that it is not very easy to hire people to review drugs at the FDA. They have to be pretty aware o

These are both good points, but it is also important to note that it is not very easy to hire people to review drugs at the FDA. They have to be pretty aware of the state-of-the-art in their field in order to be able to effectively provide guidance to the drug companies.